Polynovo Limited (ASX:PNV)
PolyNovo (ASX:PNV) develops innovative medical devices utilising the patented bioabsorbable polymer technology Novosorb®.
NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways.